Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

[SMM Analysis: Energy density twice that of LFP! Major breakthrough in US Factorial Energy's solid-state battery] Factorial Energy has achieved a major breakthrough in developing large-scale ...

Automaker Stellantis and Massachusetts-based battery startup Factorial Energy have announced validation of a new solid-state electric vehicle battery that could be a game-changer for the industry.

Semi-solid-state battery cells engineered by Factorial Energy complete successful validation test with automaker Stellantis. Factorial's FEST (Factorial Electrolyte System Technology) battery cells ...

Automotive giant Stellantis and Massachusetts-based solid-state battery technology company Factorial Energy today announced the successful validation of Factorial’s automotive-sized FEST (Factorial ...

In a move that signals a transformative shift in the electric vehicle landscape, Stellantis N.V. and Factorial Energy announced today the successful validation of automotive-sized solid-state battery ...